SRPT

Sarepta Therapeutics
SRPT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.56B
EV
$4.39B
Shares Outstanding
98.28M
Beta
0.60

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$89.96
P/E 2025E
20.07x
P/Revenue 2025E
1.39x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Sarepta Therapeutics, Inc.

gainify
SRPT

Sarepta Therapeutics, Inc.

SRPT

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection...

Sector

Healthcare

Industry

Biotechnology

CEO

Ingram, Douglas

Employees

1,372

IPO Date

1997-06-04

Headquarters

215 First Street, Suite 415, Cambridge, Massachusetts, 02142, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.